Biological variability and specificity of lipoprotein-associated phospholipase A2 (Lp-PLA2), a novel marker of cardiovascular risk

被引：0
|
作者：
Wolfert, RL [1 ]
Kim, NW [1 ]
Selby, RG [1 ]
Sarno, MJ [1 ]
Warnick, RG [1 ]
Sudhir, K [1 ]
机构：
[1] diaDexus Inc, San Francisco, CA USA
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1477
引用
收藏
页码：309 / 309
页数：1
相关论文
共 50 条
  • [31] Functional impairment of two novel mutations detected in lipoprotein-associated phospholipase A2 (Lp-PLA2) deficiency patients
    Mitsuaki Ishihara
    Tadao Iwasaki
    Makoto Nagano
    Jun Ishii
    Mayumi Takano
    Takeshi Kujiraoka
    Masahiro Tsuji
    Hiroaki Hattori
    Mitsuru Emi
    Journal of Human Genetics, 2004, 49 : 302 - 307
  • [32] The effect of percutaneous coronary intervention on transcoronary lipoprotein-associated phospholipase A2 (LP-PLA2) concentration
    Munir, M. S.
    Ahmed, A. H.
    Brewer, M. A.
    Shankar, K. J.
    Williams, S.
    Casscells, S. W.
    Wilson, J. M.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 40 (06) : 898 - 899
  • [33] Characterising the role of lipoprotein-associated phospholipase A2 (Lp-PLA2) in experimental autoimmune uveoretinitis (EAU)
    Beers, G.
    Boldison, J.
    Copland, D.
    Adamson, P.
    Nicholson, L.
    Dick, A.
    IMMUNOLOGY, 2013, 140 : 51 - 51
  • [34] Lipoprotein-associated phospholipase A2 (Lp-PLA2) - possible diagnostic and risk biomarker in chronic ischaemic heart disease
    Diaconu, Adriana
    Coculescu, Bogdan-Ioan
    Manole, Gheorghe
    Vultur, Horaiiu
    Coculescu, Elena Claudia
    Stocheci, Cristina Maria
    Tudorache, Ioan-Sorin
    Dinca, Alexandra-Ligia
    Dinca, Valeriu Gabi
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021, 36 (01) : 68 - 73
  • [35] Functional impairment of two novel mutations detected in lipoprotein-associated phospholipase A2 (Lp-PLA2) deficiency patients
    Ishihara, M
    Iwasaki, T
    Nagano, M
    Ishii, J
    Takano, M
    Kujiraoka, T
    Tsuji, M
    Hattori, H
    Emi, M
    JOURNAL OF HUMAN GENETICS, 2004, 49 (06) : 302 - 307
  • [36] The Association Between Lipoprotein Associated Phospholipase A2 (Lp-PLA2) and Cardiovascular Disease Risk in an Irish Population
    Dunleavy, E.
    Louw, M.
    Mason, J.
    Rochev, Y.
    Hutchinson, K.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2013, 182 : S405 - S405
  • [37] Lipoprotein-associated phospholipase A2:: a novel marker of cardiovascular risk and potential therapeutic target
    Macphee, C
    Benson, GM
    Shi, Y
    Zalewski, A
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (06) : 671 - 679
  • [38] Lipoprotein-associated phospholipase A2 (Lp-PLA2) and markers of oxidative stress in patients with acute heart failure
    Charniot, J. -C.
    Cosson, C.
    Albertini, J. P.
    Bittar, R.
    Giral, P.
    Cherfils, C.
    Guillerm, E.
    Bonnefont-Rousselot, D.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2010, 12 (0F) : F19 - F20
  • [39] Lipoprotein-associated phospholipase A2 (LP-PLA2) may ascertain plaque instability and predict ischemic stroke
    Danihel, L.
    Madarasz, S.
    Blazicek, P.
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 129 - 129
  • [40] Effect of recombinant lipoprotein-associated phospholipase A2 (Lp-PLA2) on cholesterol efflux from macrophages in culture
    Petraki, M.
    Chroni, A.
    Tselepis, A.
    FEBS JOURNAL, 2008, 275 : 424 - 424
12345